Should You Buy Flexion Therapeutics Inc (FLXN) Stock After it Has Risen 10.08% in a Week?

Tuesday, August 24, 2021 10:44 AM | InvestorsObserver Analysts

Mentioned in this article

Should You Buy Flexion Therapeutics Inc (FLXN) Stock After it Has Risen 10.08% in a Week?

The market has been high on Flexion Therapeutics Inc (FLXN) stock recently. FLXN gets a Bullish score from InvestorsObserver Stock Sentiment Indicator.

Flexion Therapeutics Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on FLXN!

See Full FLXN Report

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Sentiment is how investors, or the market, feels about a stock. There are lots of ways to measure sentiment. At the core, sentiment is pretty easy to understand. If a stock is going up, investors must be bullish, while if it is going down, sentiment is bearish. InvestorsObserver’s Sentiment Indicator looks at price trends over the past week and also considers changes in volume. Increasing volume can mean a trend is getting stronger, while decreasing volume can mean a trend is nearing a conclusion. For stocks that have options, our system also considers the balance between calls, which are often bets that the price will go up, and puts, which are frequently bets that the price will fall.

What's Happening With FLXN Stock Today?

Flexion Therapeutics Inc (FLXN) stock is lower by -4.12% while the S&P 500 is higher by 0.25% as of 10:41 AM on Tuesday, Aug 24. FLXN is down -$0.22 from the previous closing price of $5.46 on volume of 253,019 shares. Over the past year the S&P 500 has risen 30.88% while FLXN is down -53.67%. FLXN lost -$1.92 per share in the over the last 12 months.

More About Flexion Therapeutics Inc

Flexion Therapeutics Inc is a United States-based specialty pharmaceutical company. The company focuses on the development and commercialization of novel, local therapies. The company specializes in the treatment of patients with musculoskeletal conditions beginning with osteoarthritis. The products offered by company are zilretta which is used for enhancing the clinical effect of intra-articular corticosteroid treatment. Click Here to get the full Stock Report for Flexion Therapeutics Inc stock.